Clinical Trials Logo

Clinical Trial Summary

The aortic valve bicuspidia (BVA) is a congenital condition corresponding to the presence of 2 sigmoids instead of 3. This is the most common cardiac congenital anomaly affecting 0.5 to 2% of the population The general rule. BVA may be associated with structural damage to the ascending aorta, which exposes BVA patients to a risk of developing ascending aortic aneurysm and acute aortic accidents. Recent data from the literature have revealed that the natural history of BVA is marked by a possible development towards significant valvulopathy and / or an ascending aortic aneurysm often requiring surgical treatment. However, the natural history of bicuspid disease remains poorly understood and the prognostic factors for progression to severe valvulopathy and / or aneurysmal dilatation of the ascending aorta remain to be determined.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03139786
Study type Observational
Source Centre Hospitalier Universitaire, Amiens
Contact Christophe TRIBOUILLOY, PhD
Phone +33322455885
Email tribouilloy.christophe@chu-amiens.fr
Status Recruiting
Phase
Start date October 14, 2011
Completion date July 2025

See also
  Status Clinical Trial Phase
Completed NCT04205474 - Aortic Valve Dynamics During Exercise After Valve Sparing Root Replacement Surgery N/A